Research and Markets has announced the addition of the "African Pharmaceuticals Market, Forecast to 2020" report to their offering.

The pharmaceuticals market in Africa is expected to reach a business opportunity of $45 billion in 2020, propelled by a convergence of changing economic profiles, rapid urbanisation, increased healthcare spending and investment, and increasing incidence of chronic lifestyle diseases.

The tropical climate of Africa makes the continent the largest reservoir of infectious diseases, particularly malaria, tuberculosis (TB), and acquired immune deficiency syndrome (AIDS), besides frequent outbreaks of polio, meningitis, cholera, pandemic influenza, yellow fever, measles, hepatitis, and tetanus. With the increasing adoption of Western lifestyle in Africa, there has been a paradigm shift in the burden of illness towards non-communicable diseases (NCDs), driving the demand for chronic prescription drugs. While continuing to suffer from infectious and parasitic illness, lifestyle diseases such as cardiovascular diseases, diabetes, and cancer will witness high growth rates throughout the forecast period.

The World Health Organisation predicts that the proportional contribution of NCDs to the healthcare burden in Africa will rise by 21% through 2030. The growing middle class is a key driving force for pharmaceuticals spending. Limited affordability of governments and the general population for healthcare and pharmaceuticals and a high reliance on donor funding will be the major market restraints.

Key Topics Covered:

1. Executive Summary

- Market Themes

- Key Findings

2. Market Overview

- Key Products and Segments

- Impact of Healthcare Industry Mega Trends on the SSA Pharmaceuticals Market

- Pharmaceutical Imports

- Revenue Forecast

- Key Challenges in African Pharmaceuticals Manufacturing

- Key Challenges in African Pharmaceuticals Supply Chain

3. Market Analysis-Nigeria

- Market Segmentation-Prescription Vs OTC

- Market Segmentation and Size-Generic Vs Branded

- Prescription Market-Revenue Breakdown by Therapeutic Segments

- Prescription Market-Percent Revenue Breakdown by Products

- OTC Market-Revenue Breakdown by Therapeutic Segments

- Purchasing and Procurement

- Pharmaceuticals Market Trends

- Pricing Analysis

- Regulatory Environment

- Pharmaceuticals Market-List of Key Participants

- Nigeria-Competitive Factors and Assessment

4. Market Analysis-Kenya

- Market Overview

- Market Segmentation-Prescription Vs OTC

- Market Segmentation and Size-Generic Vs Branded

- Prescription Market-Revenue Breakdown by Therapeutic Segments

- Prescription Market-Percent Revenue Breakdown by Products

- OTC Market-Revenue Breakdown by Therapeutic Segments

- Purchasing and Procurement

- Pharmaceuticals Market Trends

- Pricing Analysis

- Regulatory Environment

- Pharmaceuticals Market-List of Key Participants

- Kenya-Competitive Factors and Assessment

5. Conclusions and Recommendations

- Key Areas of Focus for Pharmaceutical Portfolio

- Pharmaceutical Manufacturing

- Conclusions and Recommendations

6. The Last Word

For more information about this report visit http://www.researchandmarkets.com/research/5j3ps4/african